Invention Grant
US09255125B2 Polynucleotides encoding extracellular-signal-regulated kinase (ERK) heteropolyligand polypeptides
有权
编码细胞外信号调节激酶（ERK）杂多肽多肽的多核苷酸
- Patent Title: Polynucleotides encoding extracellular-signal-regulated kinase (ERK) heteropolyligand polypeptides
- Patent Title (中): 编码细胞外信号调节激酶（ERK）杂多肽多肽的多核苷酸
-
Application No.: US13612458Application Date: 2012-09-12
-
Publication No.: US09255125B2Publication Date: 2016-02-09
- Inventor: Thomas David Reed
- Applicant: Thomas David Reed
- Applicant Address: US VA Blacksburg
- Assignee: Intrexon Corporation
- Current Assignee: Intrexon Corporation
- Current Assignee Address: US VA Blacksburg
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C07K14/00
- IPC: C07K14/00 ; A61K38/00 ; A61K38/16 ; C12P21/02 ; C07K14/47 ; C12N15/62 ; C12N15/85
Abstract:
The invention relates to kinase inhibitor ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate ERK activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
Public/Granted literature
- US20140099668A1 ERK Ligands and Polynucleotides Encoding ERK Ligands Public/Granted day:2014-04-10
Information query
